FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $261,516 | -21.4% | 58,900 | -41.6% | 0.00% | 0.0% |
| Q2 2023 | $332,610 | -63.5% | 100,791 | -68.5% | 0.00% | -75.0% |
| Q1 2023 | $911,176 | +499.5% | 319,711 | +933.5% | 0.00% | +300.0% |
| Q2 2022 | $152,000 | -78.8% | 30,936 | +1.9% | 0.00% | -66.7% |
| Q1 2022 | $718,000 | +111.2% | 30,369 | +57.9% | 0.00% | +200.0% |
| Q4 2021 | $340,000 | +104.8% | 19,229 | +38.6% | 0.00% | -75.0% |
| Q1 2020 | $166,000 | – | 13,878 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |